Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px
Organisation › Details


The eTRANSAFE partners are: 1. Fundació Institut Mar d'Investigacions Mèdiques (IMIM) 2. Synapse Research Management Partners S.L. 3. Lhasa Limited 4. European Molecular Biology Laboratory (for ELIXIR) 5. Erasmus Universitair Medisch Centrum Rotterdam 6. Universiteit Leiden 7. Universität Wien 8. Simcyp Limited 9. Molecular Networks GmbH – Computerchemie 10. Optibrium Limited 11. Liverpool John Moores University 12. Fraunhofer-Gesellschaft zur Foerderung der Angewandten Forschung e.V. 13. PDS Computer Software Limited 14. Universitat Pompeu Fabra 15. Novartis Pharma AG 16. Bayer AG 17. Sanofi-Aventis Deutschland GmbH 18. Hoffmann-La Roche AG 19. Merck KGaA 20. Janssen Pharmaceutica NV 21. Institute de Recherche Internationales Servier 22. AbbVie Inc 23. AstraZeneca AB 24. Boehringer Ingelheim International GmbH 25. Clarivate Analytics 26. IPSEN Innovation SAS eTRANSAFE is funded through the Innovative Medicines Initiative (IMI), Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. eTRANSAFE has received support from IMI2 Joint Undertaking under Grant Agreement No. 777365. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. *


Period Start 2017-10-10 existent
  Group Innovative Medicines Initiative (IMI)
Products Industry drug discovery
  Industry 2 drug development
Region Region EU (European Union)
  City n. a. 
    Address record changed: 2017-10-23
Basic data Employees n. a.
    * Document for �About Section�: Optibrium Ltd.. (10/10/17). "Press Release: Optibrium Joins EUR 40 Million eTRANSAFE Project". Cambridge.
Record changed: 2017-10-23


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Innovative Medicines Initiative (IMI)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px

» top